CSE TV Presents #HashtagFinance - Chris Moreau on how Science Fiction has Inspired...


CHRIS MOREAU ON HOW SCIENCE FICTION HAS INSPIRED A POTENTIALLY LUNG-SAVING THERAPY


CSE's Barrington Miller was recently joined by Christopher Moreau, CEO of Algernon Pharmaceuticals Inc. (CSE:AGN), to discuss his company's work to develop NP-120 (Ifenprodil) as a new therapeutic in the fight against COVID-19.


In this discussion, Chris outlines how his company focuses on drug re-purposing, a term that is widely understood through the example provided by Viagra (1:04), the important distinction between therapeutic treatments and anti-virals and vaccines (12:14), and why the "grandaddy" of all market approvals is from the USFDA (18:25).


Listen until the end to hear how the company's name is actually inspired by the title of a science fiction novel, and how the company has a history of investigating compounds developed by the Soviet Union!


(Subsequent to this chat, Algernon announced Health Canada approval to move forward with its PH2b/3 trial here with Ifenprodil as a potential treatment for COVID-19.)


Related Links

algernonpharmaceuticals.com

SOURCE


#Technology #MedicalTechnology #Medtech #DrugDiscovery #MedicalResearch #MedicalDevices #PharmaceuticalDevelopment #BreathAnalysis #FAIMS #DrugRepurosing #RespiratoryMedicine #RespiratoryIllness #ClinicalTrials #HumanTrials #MedicalTechnology #MedicalAdvancements #DrugDevelopment #Research #MedicalBreakthrough #Coronavirus #COVID19 #Biotech #BiotechStocks #InvestinginHealthcare #InvestinginMedicine #SmallCapStocks #FrontierMCG




Recent Posts

See All

Toronto | Montreal | Calgary | Vancouver

https://www.frontiermcg.com